Anastasis Biosensor for Detecting Apoptosis Reversal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for studying the newly discovered process of anastasis, which is the reversal of apoptosis, particularly in understanding the molecular mechanisms and identifying specific regulators, as existing tools do not effectively allow for the observation and analysis of cells reversing apoptosis in living organisms.
Innovation Solution
Development of an in vivo biosensor system that includes a caspase-activatable transcription factor complex linked to a transmembrane domain, with a reporter system using fluorescent proteins to mark cells that survive caspase activation, enabling the study of anastasis in Drosophila and transgenic mice, particularly in photoreceptor cells and other difficult-to-replace cell types like neurons and heart cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional apoptosis study methods are used, then cell death can be observed, but the reversal process (anastasis) cannot be detected or studied
Solution Approach 1:
The biosensor system performs preliminary action by pre-marking cells with fluorescent proteins before apoptosis occurs. The system includes a caspase-activatable transcription factor complex that, upon caspase activation during apoptosis, triggers permanent fluorescent marking of the cell. This preliminary marking enables subsequent detection of cells that reverse apoptosis (anastasis), which would otherwise be undetectable using traditional methods.
2Measurement precision
If fluorescent marking is used to track apoptotic cells, then anastasis can be detected, but the biosensor system becomes complex
Solution Approach 1:
The biosensor system merges multiple functions into a single integrated construct: the caspase-activatable transcription factor complex combines the caspase sensor domain, transcription factor activity, and promoter activation elements. Upon caspase activation, the complex permanently marks the cell through fluorescent protein expression while simultaneously providing information about the apoptotic event. This merging reduces the need for separate tracking systems and simplifies the overall experimental approach.
Solution Approach 2:
The caspase-activatable transcription factor complex acts as an intermediary between caspase activation and fluorescent marking. Instead of directly linking caspase to fluorescent protein expression, the system uses the transcription factor complex as a mediator that translates the biochemical caspase signal into a permanent genetic marking event through promoter activation. This intermediary approach enables reliable and permanent marking while maintaining system modularity.
3Measurement precision
If permanent fluorescent marking is implemented, then surviving apoptotic cells can be identified, but genetic alterations may occur
Solution Approach 1:
The biosensor system extracts only the essential function needed for anastasis detection: permanent genetic marking through fluorescent protein expression. By using a minimal promoter activation approach rather than introducing complex transgenic elements or viral vectors, the system reduces the risk of additional genetic alterations. The marking is achieved through activation of endogenous or minimally modified promoter-fluorophore constructs, minimizing genetic disruption while maintaining detection capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biosensor system allows for the identification of cells that undergo anastasis, providing insights into the molecular mechanisms and potential regulators of this process, which can lead to new strategies for treating degenerative diseases and cancer, as well as enhancing our understanding of evolution and cellular survival mechanisms.
Implementation Method 1
an enzyme cleavable linker, wherein the transcription factor complex is tethered to the plasma membrane via a transmembrane domain
Implementation Method 2
a reporter system comprising (1) a first nucleic acid encoding flippase operably linked to the upstream activating sequence that binds Gal4; and (2) a second nucleic acid comprising an FRT-flanked stop codon cassette separating a constitutive promoter and a fluorescent protein open reading frame
Data Source
AI summary
The present invention relates to the field of anastasis, i.e., the process of reversal of apoptosis. More specifically, the present invention provides methods and compositions useful for studying anastasis. In one embodiment, the present invention provides an in vivo biosensor comprising (a) a transcription factor complex comprising the Gal4 transcription factor linked to an enzyme cleavable linker, wherein the transcription factor complex is tethered to the plasma membrane via a transmembrane domain; and (b) a reporter system comprising (1) a first nucleic acid encoding flippase operably linked to the upstream activating sequence that binds Gal4; and (2) a second nucleic acid comprising an FRT-flanked stop codon cassette separating a constitutive promoter and a fluorescent protein open reading frame.